HIV 1 News and Research

RSS

Potential human health risk from illegal wildlife trade

An article released today in PLoS ONE entitled, Zoonotic Viruses Associated with Illegally Imported Wildlife Products, from a collaborative study led by the U.S. Centers for Disease Control and Prevention (CDC), identified evidence of retroviruses and herpesviruses in illegally imported wildlife products confiscated at several U.S. international airports, including John F. Kennedy International Airport, George Bush Intercontinental-Houston and Atlanta Hartsfield-Jackson International.

11 Jan 2012

Rwanda working to meet 2013 goal to medically circumcise 50% of men for HIV prevention

Rwanda is expanding its medical male circumcision program this year, "as the country attempts to reach its goal of medically circumcising 50 percent of men by June 2013 as part of HIV prevention efforts," PlusNews reports.

11 Jan 2012

Starpharma receives FDA Special Protocol Assessment for bacterial vaginosis phase 3

Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA’s Special Protocol Assessment (SPA) scheme.

10 Jan 2012

Concerns over using ARV therapy as prevention strategy

PSI's "Healthy Lives" blog reviews a recent Science magazine article written by James Shelton of USAID's Bureau of Global Health in which he raises concerns about the use of antiretroviral drugs (ARVs) as a prevention strategy.

10 Jan 2012

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Sangamo BioSciences, Inc. announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS.

9 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Kenyan government adopts new HIV testing guidelines following WHO recall

"The Kenyan government has changed its HIV testing algorithm following the withdrawal of a widely used brand of HIV test [based] on warnings from" the WHO, PlusNews reports.

7 Jan 2012

HHS Secretary Sebelius discusses agency's global health strategy at KFF/HHS briefing

Speaking at a briefing on Thursday sponsored by the Kaiser Family Foundation (KFF) and the Department of Health and Human Services (HHS) to explore the department's role in global health and its Global Health Strategy, HHS Secretary Kathleen Sebelius discussed the agency's "first global health strategy ..., which explains the Obama administration's priorities during an era of budget-cutting," CQ HealthBeat reports.

7 Jan 2012

Street News Service/IPS examine challenges of fighting HIV/AIDS in a Senegalese prison

Street News Service/Inter Press Service examines how Senegal is addressing HIV/AIDS among prisoners in a Dakar maximum-security facility. "Prisons are high-risk environments for the transmission of the disease, due to the prevalence of hard drugs, violence and sexual relations," the news service writes and discusses how addressing such issues can present challenges in the majority-Muslim country.

7 Jan 2012

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Today's research comes from the Annals of Internal Medicine, the Journal of the American Medical Association, the Archives of Pediatrics and Adolescent Medicine, George Washington University and the Robert Wood Johnson Foundation.

7 Jan 2012

FDA approval of raltegravir offers new weapon to treat HIV infection in children

For children and adolescents with HIV infection, the recent Food and Drug Administration (FDA) approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in children.

7 Jan 2012

UNC HIV researcher Cohen discusses his work, HPTN 052

PSI's "Healthy Lives" blog features a video from the UNC Medical Center News Office in which Myron Cohen, a professor of medicine, microbiology, immunology and public health at the University of North Carolina-Chapel Hill and the director of the Institute for Global Health and Infectious Diseases, discusses his research into HIV/AIDS prevention, including his lead role in HPTN 052.

6 Jan 2012

New HIV vaccine candidates show promise in monkeys

"The quest for a vaccine against AIDS is gaining momentum, with research published Wednesday identifying promising new candidates that protected monkeys against a powerful strain of the virus and that soon could be tested in humans," the Wall Street Journal reports.

6 Jan 2012

British Columbia's 'treatment-as-prevention strategy' helping to reduce HIV/AIDS cases, deaths

"New HIV cases and AIDS deaths are both going steadily down in British Columbia, according to data released last week," the New York Times reports.

6 Jan 2012

Novel vaccine combinations can protect against infection by SIV

Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.

5 Jan 2012

Doctors may need to adjust seizure drug doses for people with HIV/AIDS: New AAN guideline

A new guideline issued by the American Academy of Neurology recommends doctors use caution when choosing seizure drugs for people with HIV/AIDS to avoid potential drug interactions.

5 Jan 2012

Ethiopia's PMTCT plan needs men to participate in order to reach goal, experts say

"Ethiopia's new plan to eliminate mother-to-child HIV transmission by 2015 cannot be attained unless men are more meaningfully involved in reproductive health, experts say," PlusNews reports.

5 Jan 2012

Investigational HSV vaccine shows promise against two genital herpes diseases

An investigational vaccine protected some women against infection from one of the two types of herpes simplex viruses that cause genital herpes, according to findings in the New England Journal of Medicine.

5 Jan 2012

Study reveals factors associated with prevention, control of HIV infection

New vaccine research in monkeys suggests that scientists are homing in on the critical ingredients of a protective HIV vaccine and identifies new HIV vaccine candidates to test in human clinical trials.

5 Jan 2012

Viewpoints: Sebelius on 'essential benefits'; WSJ columnist on Democrats' 'Mediscare' argument - is it a lie?

Insurance needs and health systems vary state to state, and experience tells us that the best way forward is not to mandate a one-size-fits-all answer. Instead, our approach gives states the flexibility to take their own paths, while ensuring they all end up in the best place possible: with an Affordable Insurance Exchange that offers access to comprehensive, quality, affordable health insurance to small business owners and individuals who currently have few good choices in an expensive and broken market.

5 Jan 2012

HIV 1 News and Research

Potential human health risk from illegal wildlife trade

Rwanda working to meet 2013 goal to medically circumcise 50% of men for HIV prevention

Starpharma receives FDA Special Protocol Assessment for bacterial vaginosis phase 3

Concerns over using ARV therapy as prevention strategy

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

MPIIB, QIAGEN partner to develop latent TB diagnostic test

Kenyan government adopts new HIV testing guidelines following WHO recall

HHS Secretary Sebelius discusses agency's global health strategy at KFF/HHS briefing

Street News Service/IPS examine challenges of fighting HIV/AIDS in a Senegalese prison

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

FDA approval of raltegravir offers new weapon to treat HIV infection in children

UNC HIV researcher Cohen discusses his work, HPTN 052

New HIV vaccine candidates show promise in monkeys

British Columbia's 'treatment-as-prevention strategy' helping to reduce HIV/AIDS cases, deaths

Novel vaccine combinations can protect against infection by SIV

Doctors may need to adjust seizure drug doses for people with HIV/AIDS: New AAN guideline

Ethiopia's PMTCT plan needs men to participate in order to reach goal, experts say

Investigational HSV vaccine shows promise against two genital herpes diseases

Study reveals factors associated with prevention, control of HIV infection

Viewpoints: Sebelius on 'essential benefits'; WSJ columnist on Democrats' 'Mediscare' argument - is it a lie?

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News